Evidence map›Paper›PMID 34047066›Full record

Observational studyCancer reports (Hoboken, N.J.)2022

Consistency between patients and families in recognizing cancer chemotherapy side effects: A questionnaire survey.

Fukuko Horio, Tokunori Ikeda, Yurimi Arake, Nodoka Kawashima, Erina Eto, Makoto Matsukura, Isao Fujii, Yuji Uchida

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fukuko HorioFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.ORCID 0000-0001-9119-1268
Tokunori IkedaFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Yurimi ArakeFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Nodoka KawashimaFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Erina EtoKumamoto Regional Medical Center, Kumamoto, Japan.
Makoto MatsukuraFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Isao FujiiFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Yuji UchidaFaculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Sojo University · JPKumamoto Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the side effects of cancer chemotherapy impair a patient's quality of life, family members' awareness of side effects may relieve patient anxiety and distress.

aimWe investigated whether patients and their families were consistent in recognizing the occurrence and severity of symptomatic side effects of chemotherapy treatment for cancer. METHODS AND

resultsThis was a prospective observational study. We administered a questionnaire survey to patients and family members to assess the frequency of occurrence (1: never, 2: almost never, 3: sometimes, 4: frequently, 5: almost always, 6: unknown) and the degree of severity (1: mild, 2: moderate, 3: severe, 4: extremely severe, 5: unknown) of physical and psychological symptoms associated with cancer chemotherapy. Weighted Kappa and Cramer coefficients were used to assess consistency between the two groups. We surveyed 20 pairs of patients (5 men, 15 women) and their families (10 men, 10 women); 17 pairs lived together. The median age was 65.5 years (interquartile [IQR], 58.75, 69.25) for patients and 61.00 years (IQR, 47.25, 71.25) for family members. Of patients, 17 had solid cancer, and three had leukemia. Family members mostly recognized objectively visible symptoms such as hair loss and development of spots and keratinization. However, it was difficult for families to detect invisible subjective symptoms such as weakness, dysesthesia, depressed mood, and unarticulated anxiety.

conclusionsThe results indicated that recognition of invisible subjective symptoms in patients undergoing chemotherapy was difficult even for family members. Therefore, a multidisciplinary approach in which various medical professionals actively communicate with both patients and families is important. Information sharing in collaboration with patients and families could increase understanding of the patient's condition and optimize patient care.

Indexed as

Quality of LifeAgedAntineoplastic AgentsAnxietyFamilyFemaleHumansMaleMiddle AgedNeoplasmsProspective StudiesPsychological DistressSurveys and QuestionnairesAntineoplastic Agentschemotherapycommunicationpatients with cancerquality of lifeside effect

Identifiers

PMID34047066
PMCPMC8789603
OpenAlexW3164389429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.